Asthmatics may soon breathe easier thanks to new breakthrough

Written By :  Dr. Kamal Kant Kohli
Published On 2022-12-05 04:15 GMT   |   Update On 2022-12-05 08:44 GMT

New research led by Edith Cowan University has made an important discovery that could lead to more effective treatments for the world's 262 million asthma sufferers.A study led by Dr Stacey Reinke (ECU) and Dr Craig Wheelock (Karolinska Institute, Sweden) found severe asthmatics have a distinct biochemical (metabolite) profile detectable in their urine, compared to mild-to-moderate asthmatics...

Login or Register to read the full article

New research led by Edith Cowan University has made an important discovery that could lead to more effective treatments for the world's 262 million asthma sufferers.

A study led by Dr Stacey Reinke (ECU) and Dr Craig Wheelock (Karolinska Institute, Sweden) found severe asthmatics have a distinct biochemical (metabolite) profile detectable in their urine, compared to mild-to-moderate asthmatics and healthy individuals.

Researchers analysed urine samples from more than 600 participants across 11 countries as part of the U-BIOPRED study, a Europe-wide initiative to identify and better understand different sub-types of severe asthma.

The research team discovered a specific type of metabolite, called carnitines, decreased in severe asthmatics. Carnitines play an important role in cellular energy generation and immune responses. Further analyses found carnitine metabolism was lower in severe asthmatics. These new findings will help enable researchers work towards new, more effective therapies for asthmatics.

A big problem for a lot of people

Dr Reinke, from ECU's Centre for Integrative Metabolomics and Computational Biology, said it is vital asthma treatment is improved. "Asthma affects 2.7 million Australians and there were 417 asthma-related deaths in Australia in 2020," she said. "Severe asthma occurs when someone's asthma is uncontrolled, despite being treated with high levels of medication and/or multiple medications.

"To identify and develop new treatment options, we first need to better understand the underlying mechanisms of the disease." One way to do this is to examine the body's chemical profile, or 'metabolome', which provides a snapshot of a person's current physiological state and gives useful insight into disease processes.

"In this case, we were able to use the urinary metabolome of asthmatics to identify fundamental differences in energy metabolism that may represent a target for new interventions in asthma control," Dr Reinke said.

Can urine really tell us what is happening in the lungs?

Dr Reinke said it can be difficult and invasive to investigate the lungs directly-but fortunately they contain a lot of blood vessels. "Therefore, any biochemical changes in the lungs can enter the blood stream, and then be excreted through the urine," she said.

"These are preliminary results, but we will continue to investigate carnitine metabolism to evaluate its potential as a new asthma treatment target."

'Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study' was published in the European Respiratory Journal.

Reference:

Stacey N. Reinke, Shama Naz, Romanas Chaleckis, Hector Gallart-Ayala, Johan Kolmert, Nazanin Z. Kermani, Angelica Tiotiu, David I. Broadhurst, Anders Lundqvist, Henric Olsson, Marika Ström, Åsa M. Wheelock, Cristina Gómez, Magnus Ericsson, Ana R. Sousa, John H. Riley, Stewart Bates, James Scholfield, Matthew Loza, Frédéric Baribaud, Per S. Bakke, Massimo Caruso, Pascal Chanez, Stephen J. Fowler, Thomas Geiser, Peter Howarth, European Respiratory Journal 2022 59: 2101733; DOI: 10.1183/13993003.01733-2021

Tags:    
Article Source : European Respiratory Journal

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News